Lifecore Property Plant Equipment from 2010 to 2024

LFCR Stock   5.00  0.62  11.03%   
Lifecore Biomedical Property Plant Equipment yearly trend continues to be relatively stable with very little volatility. Property Plant Equipment is likely to grow to about 132.6 M this year. During the period from 2010 to 2024, Lifecore Biomedical Property Plant Equipment destribution of quarterly values had range of 96.5 M from its regression line and mean deviation of  30,598,828. View All Fundamentals
 
Property Plant Equipment  
First Reported
2010-12-31
Previous Quarter
121.1 M
Current Value
132.6 M
Quarterly Volatility
34.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lifecore Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lifecore Biomedical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.4 M, Interest Expense of 19 M or Total Revenue of 121.8 M, as well as many indicators such as Price To Sales Ratio of 0.21, Dividend Yield of 0.0144 or PTB Ratio of 0.7. Lifecore financial statements analysis is a perfect complement when working with Lifecore Biomedical Valuation or Volatility modules.
  
Check out the analysis of Lifecore Biomedical Correlation against competitors.
To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.

Latest Lifecore Biomedical's Property Plant Equipment Growth Pattern

Below is the plot of the Property Plant Equipment of Lifecore Biomedical over the last few years. It is Lifecore Biomedical's Property Plant Equipment historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lifecore Biomedical's overall financial position and show how it may be relating to other accounts over time.
Property Plant Equipment10 Years Trend
Slightly volatile
   Property Plant Equipment   
       Timeline  

Lifecore Property Plant Equipment Regression Statistics

Arithmetic Mean178,841,079
Geometric Mean175,478,678
Coefficient Of Variation19.07
Mean Deviation30,598,828
Median200,027,000
Standard Deviation34,099,186
Sample Variance1162.8T
Range96.5M
R-Value(0.78)
Mean Square Error486.6T
R-Squared0.61
Significance0.0006
Slope(5,961,830)
Total Sum of Squares16278.6T

Lifecore Property Plant Equipment History

2024132.6 M
2023121.1 M
2022134.6 M
2021139 M
2020137.4 M
2019217.7 M

About Lifecore Biomedical Financial Statements

Lifecore Biomedical shareholders use historical fundamental indicators, such as Property Plant Equipment, to determine how well the company is positioned to perform in the future. Although Lifecore Biomedical investors may analyze each financial statement separately, they are all interrelated. The changes in Lifecore Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Lifecore Biomedical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Property Plant Equipment121.1 M132.6 M

Pair Trading with Lifecore Biomedical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lifecore Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifecore Biomedical will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Lifecore Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lifecore Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lifecore Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lifecore Biomedical to buy it.
The correlation of Lifecore Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lifecore Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lifecore Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lifecore Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Lifecore Stock Analysis

When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.